Pure Global

Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries - Trial NCT06144931

Access comprehensive clinical trial information for NCT06144931 through Pure Global AI's free database. This phase not specified trial is sponsored by Suez Canal University and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06144931
Recruiting
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT06144931
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries
The Impact of Pericapsular Nerve Group Block on The Duration of Post-Operative Analgesia Following Hip Joint Surgeries

Study Focus

Pain, Postoperative

PENG Block

Interventional

procedure

Sponsor & Location

Suez Canal University

Ismailia, Egypt

Timeline & Enrollment

N/A

Jun 01, 2023

Mar 01, 2024

38 participants

Primary Outcome

The time of first request of analgesia in both groups

Summary

To study the efficacy of the PENG block on the duration of postoperative analgesia. There are
 two groups of patients, who are undergoing hip joint surgeries, one group (Control Group)
 will receive spinal anesthesia only while the other group (PENG Group) will receive PENG
 block before spinal anesthesia.

ICD-10 Classifications

During surgical operation
During surgical operation
During surgical operation
Pain, unspecified
Postoperative intestinal obstruction

Data Source

ClinicalTrials.gov

NCT06144931

Non-Device Trial